PUBLISHER: The Business Research Company | PRODUCT CODE: 1946951
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946951
Peripheral vascular devices and equipment play a crucial role in the management of peripheral vascular diseases, which are characterized by the gradual and progressive impairment of blood circulation in blood vessels located outside the heart and brain, encompassing both arteries and veins. These conditions typically result from blockages, narrowing, or spasms within these vessels.
The primary categories of peripheral vascular devices and equipment include peripheral vascular stents, percutaneous transluminal angioplasty balloons, catheters, PTA guide wires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. Catheters, for instance, are tubular medical devices designed for insertion into canals, vessels, passageways, or body cavities to facilitate the injection or withdrawal of fluids or to maintain the patency of a passage. These devices find application in the treatment of damaged peripheral blood vessels and the management of blockages in peripheral blood vessels, ultimately enhancing blood circulation and supporting patient health. Various healthcare settings, including hospitals and clinics, utilize peripheral vascular devices and equipment to address these medical conditions.
Tariffs are influencing the peripheral vascular devices and equipment market by increasing costs of imported specialty metals, polymers, coatings, imaging components, and precision-manufactured catheters and stents. Hospitals and clinics in North America and Europe are most affected due to dependence on imported high-value vascular devices, while Asia-Pacific faces higher costs for export-oriented device manufacturing. These tariffs are raising procedure costs and impacting inventory planning. However, they are also encouraging regional manufacturing, local sourcing of medical-grade materials, and expanded domestic production of peripheral vascular devices.
The peripheral vascular devices and equipment market research report is one of a series of new reports from The Business Research Company that provides peripheral vascular devices and equipment market statistics, including peripheral vascular devices and equipment industry global market size, regional shares, competitors with a peripheral vascular devices and equipment market share, detailed peripheral vascular devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vascular devices and equipment industry. This peripheral vascular devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The peripheral vascular devices and equipment market size has grown steadily in recent years. It will grow from $10.29 billion in 2025 to $10.56 billion in 2026 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to increasing prevalence of peripheral artery disease, rising aging population, expansion of interventional cardiology practices, growing adoption of catheter-based therapies, increasing hospital infrastructure investments.
The peripheral vascular devices and equipment market size is expected to see strong growth in the next few years. It will grow to $13.15 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising use of bioresorbable materials, expansion of outpatient vascular procedures, growing focus on precision-guided interventions, increasing innovation in peripheral stent technologies. Major trends in the forecast period include increasing adoption of drug-coated vascular devices, rising use of minimally invasive endovascular procedures, growing demand for advanced atherectomy systems, expansion of image-guided peripheral interventions, enhanced focus on long-term device patency.
The rising healthcare expenditure is expected to drive the growth of the peripheral vascular devices and equipment market in the coming years. Healthcare expenditure refers to the total spending by individuals, organizations, or governments on healthcare-related goods and services over a given period. An increase in healthcare expenditure can result in higher demand for peripheral vascular devices and equipment, as healthcare systems invest in advanced medical technologies to improve the diagnosis and treatment of conditions such as peripheral artery disease, thereby enhancing patient care and clinical outcomes. For example, in April 2025, according to the Office for National Statistics (ONS), a UK-based producer of official statistics and the government's principal data source, government-funded healthcare spending reached USD 2.91 billion (£258 billion) in 2024, representing a real-terms increase of 2.5% compared with 2023, indicating stronger investment in healthcare delivery and equipment. Therefore, rising healthcare expenditure is contributing to the expansion of the peripheral vascular devices and equipment market.
Major companies in the peripheral vascular devices and equipment market are focusing on developing innovative products to improve the treatment of peripheral artery diseases (PAD). One such advancement is the development of larger-diameter catheters, which are designed to enhance fluid administration or drainage in medical procedures, particularly in challenging vascular conditions. A notable example of this innovation is the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) catheter, launched in March 2023 by Shockwave Medical Inc. This catheter is specifically engineered to treat calcification in large peripheral vessels, such as the iliac and common femoral arteries. The Shockwave L6 catheter uses targeted lithotripsy technology to break down calcified plaque, which can impair blood flow and complicate PAD treatment. By addressing this issue, the catheter improves the procedural success rate and reduces complications compared to traditional endovascular techniques, demonstrating how advanced product development is enhancing the effectiveness of peripheral vascular treatments.
In September 2024, Boston Scientific Corporation, a leading US-based biotechnology company, acquired Silk Road Medical Inc. for $1.18 billion. This acquisition significantly strengthens Boston Scientific's vascular technology portfolio, particularly by expanding access to Silk Road's innovative TransCarotid Artery Revascularization (TCAR) platform. The TCAR platform is designed to treat carotid artery disease, a major contributor to stroke risk. By integrating Silk Road's technology into its own, Boston Scientific aims to enhance the treatment options available to physicians and patients, ultimately improving outcomes for individuals with peripheral vascular conditions. The acquisition also allows Boston Scientific to leverage its broad commercial network to make these life-saving treatments more accessible. Silk Road Medical Inc. is recognized for its expertise in developing advanced peripheral vascular devices and equipment.
Major companies operating in the peripheral vascular devices and equipment market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cook Group, Angiomed GmbH & Co. Medizintechnik KG, Terumo Corporation, ENDOLOGIX Inc., Bolton Medical Inc., JOTEC GmbH, Clearstream Technologies, Aesculap AG, Curative Medical Devices, Lepu Medical Technology, MicroPort, Bioteque Corporation Co.Ltd., Cardinal Health, iVascular, B. Braun Group, Biosensors International Group, BIOTRONIK SE & Co., COVIDien, Volcano Corporation, AngioScore, Edwards Lifesciences Corporation, Cordis Corporation, Koninklijke Philips N.V., Nipro Corporation, Bluesail Medical Co. Ltd, Rex Medical, Teleflex Incorporated, Penumbra Inc., Lombard Medical Technologies PLC, W.L. Gore & Associates Inc., Merit Medical Systems Inc., Vascular Solutions Inc., LeMaitre Vascular Inc., Spectranetics Corporation
North America was the largest region in global peripheral vascular devices and equipment market in 2025. Western Europe was the second-largest region in global peripheral vascular devices and equipment market. The regions covered in the peripheral vascular devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the peripheral vascular devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The peripheral vascular devices and equipment market consist of sales of peripheral vascular stents, percutaneous transluminal angioplasty balloons, PTA drug-eluting balloons, embolic protection devices, inferior vena cava filters, Aortic stent-grafts, synthetic surgical drafts, and peripheral guide wires. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Peripheral Vascular Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses peripheral vascular devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for peripheral vascular devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral vascular devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.